OncoCyte Corp (OCX) PT Raised to $4.25 at Needham
Tweet Send to a Friend
Needham analyst Mike Matson raised the price target on OncoCyte Corp (NASDAQ: OCX) to $4.25 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
